Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep1335 | Late Breaking | ECE2024

Adipsic central diabetes insipidus as a result of neurosarcoidosis

Milosheska Radmila , Mickovski Ivana , Buklioska Ilievska Daniela

Background: Sarcoidosis is a multisystemic disease, the cause of which has not yet been determined. ItÂ’s characterized by the appearance of granulomas, which typically target the lungs, the lymphatic system and in rare cases, around 5-15%, changes in the nervous system are observed. Neurosarcoidosis leads to hypothalamus-pituitary axis dysfunction and the most common clinical manifestation is the onset of central diabetes insipidus.Case report: We p...

ea0081ep509 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Is Semaglutide superior than Liraglutide in patients with type 2 diabetes on insulin therapy? - case presentation

Mickovski Ivana , Buklioska-Ilievska Daniela , Milosheska Radmila , Hasan Taner

Type 2 diabetes (T2DM) is a chronic and progressive disease associated with microvascular and macrovascular complications leading to increased morbidity and mortality. Insulin remains the cornerstone therapy for longer-duration T2DM and b-cell failure. Glucagon-like peptide-1 receptor agonists are a class of multifactorial T2DM medications that have been shown to improve numerous risk factors for diabetes-related complications, including glycemic control, reduction in body wei...